Trade expert Ives gives AdvaMed stronger hand in international negotiations
This article was originally published in Clinica
Ralph Ives, the man behind the precedent-setting US-Australian Free Trade Agreement, has been chosen to lead AdvaMed's international division.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.